$0.580496
0.00991.73%
Pre-Market: Sep 20, 7:58 PM EDT
15 minutes delayed
Kezar Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kezar Life Sciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.28 | $-0.32 | 12.5 % |
Mar 2024 | 2024-05-09 | $-0.30 | $-0.33 | 9.09 % |
Dec 2023 | 2024-03-14 | $-0.44 | $-0.38 | -15.8 % |
Sep 2023 | 2023-11-13 | $-0.32 | $-0.35 | 8.57 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $0 | $750.00K | -100.0 % |
Mar 2024 | 2024-05-09 | $0 | $400.00K | -100.0 % |
Kezar Life Sciences (KZR) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.28, which beat the estimate of $-0.32.
The Actual Revenue was $0K, which missed the estimate of $750K.
Browse earnings estimates, EPS, and revenue on all stocks.